HCTI
Healthcare Triangle, Inc.
Price Chart
Latest Quote
$1.98
-0.13 (-6.16%)
Current Price
| Previous Close | $2.11 |
| Open | $2.06 |
| Day High | $2.09 |
| Day Low | $1.98 |
| Volume | 22,131 |
Stock Information
| Shares Outstanding | 2.03M |
| Total Debt | $10.87M |
| Cash Equivalents | $4.32M |
| Revenue | $20.04M |
| Net Income | $-13.97M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $4.02M |
| P/E Ratio | 0.00 |
| EPS (TTM) | $402.84 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $36.21M |
| Sales | $20.04M |
| Income | $-13.97M |
| Book/sh | $14.80 |
| Cash/sh | $2.13 |
| Employees | 41 |
Financial Ratios
| Quick Ratio | 0.67 |
| Current Ratio | 0.90 |
| Debt/Eq | 20.63 |
Returns & Margins
| ROA | -16.33% |
| ROE | -45.61% |
| Gross Margin | 19.73% |
| Operating Margin | -36.76% |
| Profit Margin | -69.72% |
Ownership
| Insider Ownership | 0.01% |
| Institutional Ownership | 5.55% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.20 |
| P/S | 0.20 |
| P/B | 0.13 |
Analyst Data
| Recommendation | none |
| Target Price | $5.00 |
Technical Indicators
| SMA20 | $2.32 |
| SMA50 | $2.32 |
| SMA200 | $61.76 |
| RSI | 32.38 |
| ATR | 0.1713 |
| Shares Float | 2.03M |
| Short Float | 4.53% |
| Short Ratio | 0.36 |
| Volatility | 1.05 |
| Rel Volume | 0.51 |
Performance History
| Week | -13.91% |
| Month | -17.84% |
| Quarter | -24.43% |
| 6 Months | -98.29% |
| YTD | -94.59% |
| Year | -99.57% |
| 3 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $1.98 | 22,131 |
| 2026-06-23 | $2.11 | 34,000 |
| 2026-06-22 | $2.10 | 73,700 |
| 2026-06-18 | $2.19 | 45,000 |
| 2026-06-17 | $2.22 | 22,000 |
| 2026-06-16 | $2.30 | 42,400 |
| 2026-06-15 | $2.23 | 40,700 |
| 2026-06-12 | $2.23 | 37,300 |
| 2026-06-11 | $2.43 | 39,700 |
| 2026-06-10 | $2.34 | 29,100 |
| 2026-06-09 | $2.36 | 34,900 |
| 2026-06-08 | $2.26 | 53,800 |
| 2026-06-05 | $2.26 | 52,900 |
| 2026-06-04 | $2.42 | 33,600 |
| 2026-06-03 | $2.35 | 43,100 |
| 2026-06-02 | $2.49 | 54,300 |
| 2026-06-01 | $2.58 | 38,200 |
| 2026-05-29 | $2.58 | 61,400 |
| 2026-05-28 | $2.61 | 82,200 |
| 2026-05-27 | $2.42 | 32,400 |
| 2026-05-26 | $2.41 | 98,900 |
About Healthcare Triangle, Inc.
Healthcare Triangle, Inc., a healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations; Blockchain infrastructure; and Cybersecurity navigator. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery capabilities on public cloud. It also serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California.
đ° Latest News
Wall Street Set to Open Little Changed as Investors Parse Earnings; Jobless Claims Data
MT Newswires âĸ 2026-02-26T14:18:09ZHealthcare Triangle announces 1-for-60 reverse stock split
TipRanks âĸ 2026-02-07T15:25:25Z
BC-Most Active Stocks
Associated Press Finance âĸ 2026-01-29T15:30:18ZHealthcare Triangle signs LOI for acquisition of Teyame.AI
TipRanks âĸ 2025-10-10T12:45:40Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $12,001,000 | $8,806,000 | $26,426,000 | $34,591,000 |
| Cost Of Revenue | $12,001,000 | $8,806,000 | $26,426,000 | $34,591,000 |
| Total Revenue | $13,891,000 | $11,696,000 | $33,203,000 | $45,886,000 |
| Operating Revenue | $13,891,000 | $11,696,000 | $33,203,000 | $45,886,000 |
| Expenses | ||||
| Interest Expense | $567,000 | $1,213,000 | $968,000 | $212,000 |
| Total Expenses | $23,663,000 | $16,277,000 | $39,188,000 | $57,843,000 |
| Other Income Expense | $863,000 | $-163,000 | $-1,698,000 | $-1,683,000 |
| Other Non Operating Income Expenses | $898,000 | $7,000 | $12,000 | - |
| Net Non Operating Interest Income Expense | $-567,000 | $-1,213,000 | $-968,000 | $-212,000 |
| Interest Expense Non Operating | $567,000 | $1,213,000 | $968,000 | $212,000 |
| Operating Expense | $11,662,000 | $7,471,000 | $12,762,000 | $23,252,000 |
| Selling And Marketing Expense | $3,084,000 | $2,203,000 | $4,670,000 | $6,650,000 |
| General And Administrative Expense | $7,337,000 | $3,950,000 | $5,727,000 | $5,522,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Net Interest Income | $-567,000 | $-1,213,000 | $-968,000 | $-212,000 |
| Normalized Income | $-9,441,000 | $-5,834,700 | $-6,976,000 | $-12,675,000 |
| Net Income From Continuing And Discontinued Operation | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Total Operating Income As Reported | $-9,789,000 | $-4,751,000 | $-7,695,000 | $-16,323,000 |
| Net Income Common Stockholders | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Net Income | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Net Income Including Noncontrolling Interests | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Net Income Continuous Operations | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Pretax Income | $-9,476,000 | $-5,957,000 | $-8,651,000 | $-13,852,000 |
| Special Income Charges | $-17,000 | $-170,000 | $-1,710,000 | $-1,683,000 |
| Operating Income | $-9,772,000 | $-4,581,000 | $-5,985,000 | $-11,957,000 |
| Depreciation Amortization Depletion Income Statement | $705,000 | $889,000 | $1,566,000 | $2,942,000 |
| Depreciation And Amortization In Income Statement | $705,000 | $889,000 | $1,566,000 | $2,942,000 |
| Gross Profit | $1,890,000 | $2,890,000 | $6,777,000 | $11,295,000 |
| Per Share | ||||
| Diluted EPS | $-152.30 | $-15749.34 | $-30159.72 | $-51462.37 |
| Basic EPS | $-152.30 | $-15749.34 | $-30159.72 | $-51462.37 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-35,700 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,169,000 | $-3,685,000 | $-4,407,000 | $-9,015,000 |
| Total Unusual Items | $-35,000 | $-170,000 | $-1,710,000 | $-1,683,000 |
| Total Unusual Items Excluding Goodwill | $-35,000 | $-170,000 | $-1,710,000 | $-1,683,000 |
| Reconciled Depreciation | $705,000 | $889,000 | $1,566,000 | $2,942,000 |
| EBITDA (Bullshit earnings) | $-8,204,000 | $-3,855,000 | $-6,117,000 | $-10,698,000 |
| EBIT | $-8,909,000 | $-4,744,000 | $-7,683,000 | $-13,640,000 |
| Diluted Average Shares | $61,872 | $379 | $288 | $279 |
| Basic Average Shares | $61,872 | $379 | $288 | $279 |
| Diluted NI Availto Com Stockholders | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Tax Provision | $0 | $12,000 | $35,000 | $506,000 |
| Write Off | $17,000 | $170,000 | $0 | - |
| Gain On Sale Of Security | $-18,000 | - | - | - |
| Research And Development | $536,000 | $429,000 | $799,000 | $8,138,000 |
| Selling General And Administration | $10,421,000 | $6,153,000 | $10,397,000 | $12,172,000 |
| Other Gand A | $7,337,000 | $3,950,000 | $5,727,000 | $5,522,000 |
| Impairment Of Capital Assets | - | $0 | $1,710,000 | $4,366,000 |
| Other Special Charges | - | - | $-12,000 | $-1,081,000 |
| Restructuring And Mergern Acquisition | - | - | $0 | $-1,602,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $4,227,000 | $-5,114,000 | $-2,248,000 | $1,955,000 |
| Total Assets | $22,736,000 | $1,961,000 | $6,858,000 | $13,262,000 |
| Total Non Current Assets | $9,585,000 | $509,000 | $1,205,000 | $5,240,000 |
| Non Current Accounts Receivable | $3,826,000 | $497,000 | $304,000 | $1,075,000 |
| Goodwill And Other Intangible Assets | $5,754,000 | $0 | $857,000 | $4,085,000 |
| Other Intangible Assets | $2,808,000 | - | $857,000 | $4,085,000 |
| Current Assets | $13,151,000 | $1,452,000 | $5,653,000 | $8,022,000 |
| Other Current Assets | $189,000 | $60,000 | $824,000 | $816,000 |
| Prepaid Assets | $3,267,000 | $262,000 | - | - |
| Receivables | $2,070,000 | $1,110,000 | $3,595,000 | $5,865,000 |
| Accounts Receivable | $2,070,000 | $1,110,000 | $3,595,000 | $5,865,000 |
| Allowance For Doubtful Accounts Receivable | $-202,000 | $-185,000 | $0 | $-222,000 |
| Gross Accounts Receivable | $2,272,000 | $1,295,000 | $3,595,000 | $5,814,000 |
| Cash Cash Equivalents And Short Term Investments | $7,625,000 | $20,000 | $1,234,000 | $1,341,000 |
| Cash And Cash Equivalents | $7,625,000 | $20,000 | $1,234,000 | $1,341,000 |
| Debt | ||||
| Net Debt | $3,112,000 | $2,630,000 | $2,651,000 | $1,344,000 |
| Total Debt | $10,737,000 | $2,650,000 | $3,885,000 | $2,685,000 |
| Current Debt And Capital Lease Obligation | $10,737,000 | $2,650,000 | $3,788,000 | $2,685,000 |
| Current Debt | $10,737,000 | $2,650,000 | $3,788,000 | $2,685,000 |
| Other Current Borrowings | - | $2,061,000 | $1,112,000 | $2,412,000 |
| Long Term Debt And Capital Lease Obligation | - | - | $97,000 | - |
| Long Term Debt | - | - | $97,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,792,000 | $7,075,000 | $8,249,000 | $7,222,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $97,000 | $625,000 |
| Current Liabilities | $12,792,000 | $7,075,000 | $8,152,000 | $6,597,000 |
| Other Current Liabilities | $97,000 | $567,000 | $2,411,000 | $2,431,000 |
| Payables And Accrued Expenses | $1,958,000 | $3,858,000 | $1,953,000 | $1,481,000 |
| Payables | $923,000 | $2,756,000 | $1,953,000 | $1,481,000 |
| Other Payable | $179,000 | $217,000 | - | - |
| Accounts Payable | $744,000 | $2,539,000 | $1,953,000 | $1,481,000 |
| Other Non Current Liabilities | - | - | $500,000 | $625,000 |
| Equity | ||||
| Common Stock Equity | $2,546,000 | $-12,549,000 | $-1,391,000 | $6,040,000 |
| Preferred Stock Equity | $7,435,000 | $7,435,000 | - | - |
| Total Equity Gross Minority Interest | $9,944,000 | $-5,114,000 | $-1,391,000 | $6,040,000 |
| Stockholders Equity | $9,981,000 | $-5,114,000 | $-1,391,000 | $6,040,000 |
| Retained Earnings | $-42,999,000 | $-33,571,000 | $-27,602,000 | $-18,916,000 |
| Other | ||||
| Ordinary Shares Number | $142,426 | $379 | $288 | $279 |
| Share Issued | $142,426 | $379 | $288 | $279 |
| Tangible Book Value | $-3,208,000 | $-12,549,000 | $-2,248,000 | $1,955,000 |
| Invested Capital | $13,283,000 | $-9,899,000 | $2,494,000 | $8,725,000 |
| Working Capital | $359,000 | $-5,623,000 | $-2,499,000 | $1,425,000 |
| Total Capitalization | $9,981,000 | $-5,114,000 | $-1,294,000 | $6,040,000 |
| Minority Interest | $-37,000 | $0 | - | - |
| Additional Paid In Capital | $45,534,000 | $21,022,000 | $26,211,000 | $24,956,000 |
| Capital Stock | $7,446,000 | $7,435,000 | $0 | $0 |
| Common Stock | $11,000 | $0 | $0 | $0 |
| Preferred Stock | $7,435,000 | $7,435,000 | $0 | $0 |
| Line Of Credit | $10,737,000 | $2,650,000 | $2,676,000 | $2,685,000 |
| Current Accrued Expenses | $1,035,000 | $1,102,000 | - | - |
| Duefrom Related Parties Non Current | $3,826,000 | $497,000 | $304,000 | $1,075,000 |
| Goodwill | $2,946,000 | $0 | $0 | $1,289,000 |
| Net PPE | $5,000 | $12,000 | $44,000 | $80,000 |
| Accumulated Depreciation | $-62,000 | $-57,000 | $-88,000 | $-39,000 |
| Gross PPE | $67,000 | $69,000 | $132,000 | $119,000 |
| Machinery Furniture Equipment | $67,000 | $69,000 | $132,000 | $119,000 |
| Preferred Shares Number | - | $6,000 | - | - |
| Treasury Shares Number | - | - | $0 | - |
| Capital Lease Obligations | - | - | $0 | $0 |
| Current Capital Lease Obligation | - | - | $0 | $0 |
| Other Properties | - | - | - | - |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-18,027,000 | $-1,081,000 | $-2,163,000 | $-6,487,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-16,523,000 | $-1,081,000 | $-2,151,000 | $-5,353,000 |
| Cash Flow From Continuing Operating Activities | $-16,523,000 | $-1,081,000 | $-2,151,000 | $-5,353,000 |
| Operating Gains Losses | $-27,000 | - | - | $-1,081,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,504,000 | - | $-12,000 | $-1,134,000 |
| Investing Cash Flow | $-1,751,000 | $0 | $-12,000 | $-1,134,000 |
| Cash Flow From Continuing Investing Activities | $-1,751,000 | $0 | $-12,000 | $-1,134,000 |
| Net Other Investing Changes | $-247,000 | - | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $25,879,000 | $-133,000 | $2,056,000 | $6,058,000 |
| Cash Flow From Continuing Financing Activities | $25,879,000 | $-133,000 | $2,056,000 | $6,058,000 |
| Net Other Financing Charges | $17,032,000 | $956,000 | $500,000 | $-294,000 |
| Cash Dividends Paid | $0 | $0 | - | - |
| Repurchase Of Capital Stock | - | - | $0 | $-141,000 |
| Issuance Of Capital Stock | - | - | $500,000 | $5,888,000 |
| Net Common Stock Issuance | - | - | $500,000 | $5,747,000 |
| Common Stock Issuance | - | - | $500,000 | $5,888,000 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $121,000 | $968,000 | $212,000 |
| Income Tax Paid Supplemental Data | $0 | $12,000 | $35,000 | $357,000 |
| End Cash Position | $7,625,000 | $20,000 | $1,234,000 | $1,341,000 |
| Beginning Cash Position | $20,000 | $1,234,000 | $1,341,000 | $1,770,000 |
| Changes In Cash | $7,605,000 | $-1,214,000 | $-107,000 | $-429,000 |
| Interest Paid Cff | $-567,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $9,414,000 | $-1,089,000 | $1,556,000 | $282,000 |
| Net Short Term Debt Issuance | $9,414,000 | $-1,089,000 | $1,556,000 | $476,000 |
| Net Intangibles Purchase And Sale | $-1,498,000 | $0 | $0 | $-1,094,000 |
| Purchase Of Intangibles | $-1,498,000 | $0 | $0 | $-1,094,000 |
| Net PPE Purchase And Sale | $-6,000 | $0 | $-12,000 | $-40,000 |
| Purchase Of PPE | $-6,000 | $0 | - | - |
| Change In Working Capital | $-8,691,000 | $2,692,000 | $2,997,000 | $3,748,000 |
| Change In Other Current Liabilities | $165,000 | $-525,000 | $-520,000 | $1,268,000 |
| Change In Other Current Assets | $-3,126,000 | $502,000 | $-8,000 | $-454,000 |
| Change In Payables And Accrued Expense | $-1,488,000 | $593,000 | $484,000 | $-392,000 |
| Change In Receivables | $-4,242,000 | $2,122,000 | $3,041,000 | $3,326,000 |
| Changes In Account Receivables | $-913,000 | $2,315,000 | $2,270,000 | $3,585,000 |
| Other Non Cash Items | $498,000 | $1,050,000 | $96,000 | $-1,449,000 |
| Stock Based Compensation | $451,000 | $87,000 | $166,000 | $257,000 |
| Asset Impairment Charge | $17,000 | $170,000 | $1,710,000 | $4,588,000 |
| Depreciation Amortization Depletion | $705,000 | $889,000 | $1,566,000 | $2,942,000 |
| Depreciation And Amortization | $705,000 | $889,000 | $1,566,000 | $2,942,000 |
| Net Foreign Currency Exchange Gain Loss | $-27,000 | $0 | - | - |
| Net Income From Continuing Operations | $-9,476,000 | $-5,969,000 | $-8,686,000 | $-14,358,000 |
| Repayment Of Debt | - | - | $0 | $-194,000 |
| Issuance Of Debt | - | - | $0 | $0 |
| Proceeds From Stock Option Exercised | - | - | $0 | $29,000 |
| Common Stock Payments | - | - | $0 | $-141,000 |
| Net Long Term Debt Issuance | - | - | $0 | $-194,000 |
| Long Term Debt Payments | - | - | $0 | $-194,000 |
| Long Term Debt Issuance | - | - | $0 | $0 |
| Net Business Purchase And Sale | - | - | $0 | $0 |
| Purchase Of Business | - | - | $0 | $0 |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-20